GLP-1 inhibits pancreatic alpha-cells, thus inhibiting glucagon secretion, although the exact mechanism by which it acts on alpha-cells is not fully understood
Known commonly as Ozempic, which is primarily prescribed to treat Type 2 diabetes, or Wegovy, its weight loss-focused variant, semaglutide has been touted as the newest answer to the American obesity epidemic [2]
Miyazaki M, Kato M, Tanaka K, Tanaka M, Kohjima M, Nakamura K, et al
If you are already sensitive to the gastrointestinal effects of a GLP-1 medication, adding a high dose of L-carnitine could make those symptoms worse
I think how this GLP-1 super cycle is going to play out if it continues, and what's interesting about the Insulin history and the analog to that, it's looking like it's going to be this ever stacking waves of patentable innovation and product innovation happening here